Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
kx43kHBgWLPTnLKP
Listen
